Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy.

Although eGFR decreased significantly as a function of postnatal age in neonates receiving amikacin, the majority (91.4%) of these neonates were able to clear the drug to < 5 mcg/mL within a 24-hour dosing interval.